DIMENHYDRINATE INJECTION USP
Google image searchProduct monograph
Active ingredient
dimenhydrinate, 250 MG/5 ML
DIN: 02435241
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Description: MUST BE DILUTED FOR I.V. USE, MULTI-DOSE VIALS, CONTAINS PRESERVATIVE
Schedule: Ethical
Company: HIKMA CANADA LIMITED
Date: 22-APR-2022
ATC:
- R06 — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD, )
- R06A — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD)
- R06AA — Aminoalkyl ethers (ATC, ATC/DDD)
- R06AA11 — DIMENHYDRINATE (ATC/DDD)
Pharmaceutical standard: USP
